- Luminex Corporation (NASDAQ:LMNX) expects Q4 revenues to be ~$72M (+20% Y/Y) and ~$271M (+14% Y/Y) for the year. Verigene-related revenues in Q4 were ~$9M (+32% Y/Y).
- 2017 Financial Guidance: The company expects fiscal 2017 revenue to be between $295 - $305M. The company intends to update its annual revenue guidance at each quarterly reporting period.
- The Company expects to release its Q4 and full year results on Feb. 6, 2017.